EyePoint Pharmaceuticals, Inc. | License Agreements | Business Contracts

Exclusive License Agreement, dated May 2, 2022, by and between EyePoint Pharmaceuticals, Inc. and Betta Pharmaceuticals, Co., Ltd (Filed With SEC on August 5, 2022)

Amendment #1 to Exclusive License Agreement, dated May 2, 2022, by and between EyePoint Pharmaceuticals, Inc. and Equinox Sciences, LLC (Filed With SEC on August 5, 2022)

Exclusive License Agreement, dated February 3, 2020, between EyePoint Pharmaceuticals, Inc. and Equinox Science, LLC (Filed With SEC on March 16, 2020)

EyePoint Pharmaceuticals, Inc. (44) | License Agreements (3)